HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Allan H Conney Selected Research

Caffeine (No Doz)

1/2013Inhibition of UVB-induced nonmelanoma skin cancer: a path from tea to caffeine to exercise to decreased tissue fat.
1/2013Oral caffeine during voluntary exercise markedly inhibits skin carcinogenesis and decreases inflammatory cytokines in UVB-treated mice.
1/2013Mechanisms of Caffeine-Induced Inhibition of UVB Carcinogenesis.
1/2012Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.
8/2011Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase.
7/2011Caffeine decreases phospho-Chk1 (Ser317) and increases mitotic cells with cyclin B1 and caspase 3 in tumors from UVB-treated mice.
7/2011Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice.
7/2009ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine.
4/2008Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice.
3/2008Effect of caffeine on UVB-induced carcinogenesis, apoptosis, and the elimination of UVB-induced patches of p53 mutant epidermal cells in SKH-1 mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Allan H Conney Research Topics

Disease

46Neoplasms (Cancer)
11/2014 - 08/2002
19Prostatic Neoplasms (Prostate Cancer)
11/2014 - 11/2003
11Skin Neoplasms (Skin Cancer)
01/2013 - 09/2002
8Sunburn
01/2014 - 01/2002
8Body Weight (Weight, Body)
01/2014 - 09/2007
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2014 - 10/2005
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2014 - 09/2002
5Breast Neoplasms (Breast Cancer)
03/2011 - 11/2003
4Colonic Neoplasms (Colon Cancer)
01/2013 - 11/2003
3Myeloid Leukemia (Leukemia, Myelocytic)
06/2015 - 02/2005
3Inflammation
01/2014 - 06/2011
3Ataxia Telangiectasia (Louis Bar Syndrome)
08/2011 - 04/2008
2Keratoacanthoma
02/2014 - 06/2012
2Hyperplasia
03/2008 - 08/2005
2Obesity
01/2008 - 10/2006
1Edema
10/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Melanoma (Melanoma, Malignant)
01/2013
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2012
1Hypercalcemia (Milk Alkali Syndrome)
11/2008
1Adenocarcinoma
04/2008
1Actinic Keratosis
11/2007

Drug/Important Bio-Agent (IBA)

19Caffeine (No Doz)FDA LinkGeneric
01/2013 - 01/2002
8CurcuminIBA
09/2014 - 11/2003
8Caspase 3 (Caspase-3)IBA
06/2012 - 01/2002
7TeaIBA
01/2013 - 01/2002
5celecoxib (Celebrex)FDA Link
07/2014 - 09/2007
5atorvastatin (Lipitor)FDA Link
07/2014 - 09/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2013 - 11/2003
4sulforafan (sulforaphane)IBA
03/2014 - 08/2006
4Estradiol (Estrace)FDA LinkGeneric
04/2008 - 08/2002
3CoffeeFDA Link
01/2013 - 11/2007
3Estrogens (Estrogen)FDA Link
11/2008 - 08/2004
3EnzymesIBA
01/2008 - 08/2004
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
11/2003 - 01/2002
2Interleukin-6 (Interleukin 6)IBA
02/2014 - 01/2012
2CytokinesIBA
01/2013 - 06/2012
2AdipokinesIBA
01/2013 - 06/2012
2Phosphotransferases (Kinase)IBA
01/2013 - 08/2011
2Cyclin B1IBA
07/2011 - 04/2008
2Biological Markers (Surrogate Marker)IBA
06/2011 - 12/2004
2Vitamin DFDA LinkGeneric
03/2011 - 11/2008
2CalciumIBA
03/2011 - 02/2004
2ClofibrateFDA Link
04/2008 - 08/2004
23- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
01/2008 - 10/2005
2NF-kappa B (NF-kB)IBA
01/2008 - 10/2005
2Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2005 - 03/2004
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2004 - 11/2003
2TamoxifenFDA LinkGeneric
02/2004 - 11/2003
2Finasteride (Propecia)FDA LinkGeneric
02/2004 - 11/2003
1TomatineIBA
06/2015
1Vitamin EFDA LinkGeneric
11/2014
1antineoplaston A10 (A 10)IBA
09/2014
1Androgen Receptors (Androgen Receptor)IBA
09/2014
1tipifarnib (R115777)IBA
06/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2014
1isothiocyanic acidIBA
03/2014
1InterleukinsIBA
02/2014
1ParaffinIBA
02/2014
11,2,5,6-dibenzanthracene (dibenz(a,h)anthracene)IBA
09/2013
1trans-1,2-dihydro-1,2-naphthalenediolIBA
09/2013
1pyridineIBA
04/2013
1ligustilideIBA
03/2013
1Pyrimidine DimersIBA
01/2013
1gemcitabineFDA Link
12/2012
1salicylhydroxamic acid (SHAM)IBA
06/2012
11,25- dihydroxy- 21- (3- hydroxy- 3- methyl- 4,4,4- tributyl)- 23- yne- 26,27- hexafluorocholecalciferolIBA
03/2011
1TocopherolsFDA Link
01/2011
1Small Interfering RNA (siRNA)IBA
07/2009
1Cyclic AMP (AMP, Cyclic)IBA
07/2009
1eucerinIBA
02/2009
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
11/2008
1Cholecalciferol (Vitamin D3)FDA Link
11/2008
1Insulin-Like Growth Factor Binding Protein 3IBA
11/2008
1Cyclin-Dependent Kinase Inhibitor p21IBA
11/2008
1sodium benzoate drug combination caffeineIBA
03/2008
1Tetrachlorodibenzodioxin (TCDD)IBA
01/2008
1ThymineIBA
01/2007
1Dietary Fats (Ghee)IBA
10/2006
1Staphylococcal Protein A (A, Protein)IBA
08/2006
1anthraceneIBA
08/2006
1Heme Oxygenase-1IBA
08/2006
1Paclitaxel (Taxol)FDA LinkGeneric
06/2006
1Phenobarbital (Luminal)FDA Link
05/2006
1CholesterolIBA
05/2006
1phenethyl isothiocyanate (PEITC)IBA
01/2006
1phorbolIBA
10/2005
1Transcription Factors (Transcription Factor)IBA
10/2005
1prolylleucineIBA
05/2005
1prolyl-serine (Pro-Ser)IBA
05/2005
1Codon (Codons)IBA
05/2005
1Capsaicin (Zostrix)FDA Link
02/2005

Therapy/Procedure

14Heterologous Transplantation (Xenotransplantation)
11/2014 - 10/2005
8Injections
06/2014 - 03/2004
7Oral Administration
10/2013 - 01/2002
2Aftercare (After-Treatment)
08/2005 - 07/2004
2Chemoprevention
02/2004 - 11/2003
1Lipectomy (Liposuction)
06/2012
1Castration
01/2010
1Subcutaneous Injections
06/2008